Rational Design of a Potent, Selective, and Metabolically Stable CDK9 Inhibitor to Counteract Osimertinib Resistance Through Mcl-1 Suppression and Enhanced BRD4 Co-Targeting.
Journal of medicinal chemistry(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要